PROC Procaps Group Corp: Koefisien utang jangka dawa marang modal

Simbol lan logo merek Procaps Group Corp (PROC)

Procaps Group S.A. (PROC) owns modern facilities in the US and Latin America, ensuring the reliability of pharmaceutical supplies. This price trend chart on GURU.Markets shows the metric at 0.00, while market distrust is driven by management turnover and reporting errors. Procaps Group S.A. (PROC) is mitigating threats by providing contract services to hundreds of clients and developing its own private labels.

PROC - Utang jangka dawa marang ekuitas Procaps Group ing rentang 04.07.2022 - 16.02.2025
Barang utama Procaps Group S.A.

The stability of Procaps Group S.A. (PROC) relies on the loyalty of its engineering staff in Latin America. An analysis of long-term debt-to-equity allows for an assessment of how effectively the company finances its expansion amid the current rotation of financial management. This metric compares liabilities with maturities exceeding one year against shareholders' equity, revealing the extent of the debt load. A decrease in this ratio confirms financial resilience. A rational balance of this indicator justifies the fair market value of the asset.

Karo sapa Procaps Group S.A. saingan

Kewajiban jangka dawa marang ekuitas Haleon PLC|Kenvue Corp (KVUE) - Utang jangka dawa marang modal|Koefisien utang jangka dawa marang modal Verona Pharma Inc. (VRNA)|Utang jangka dawa marang modal MENS (Jyong Biotech Ltd)|ligand.com - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Amneal (AMRX)|PRGO: Koefisien utang jangka dawa marang modal|ALVO (Alvotech Corp) - Utang jangka dawa marang ekuitas|Liquidia Inc. (LQDA) - Rasio utang jangka dawa marang ekuitas|GLPG (Galapagos NV) - Utang jangka dawa marang modal|Utang jangka dawa marang modal anipharmaceuticals.com (ANIP)|MannKind (MNKD) - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal AMPH (Amphastar Pharmaceuticals Inc)|PCRX: Utang jangka dawa marang ekuitas|SPRY - Kewajiban jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Theravance Biopharma TBPH|AQST - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang modal scpharmaceuticals.com SCPH|Tectonic Therapeutic (TECX) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal TNXP (Tonix Pharmaceuticals Inc.)|Kewajiban jangka dawa marang modal SXTC|Eupraxia Pharmaceuticals (EPRX) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal BHST (bioharvest.com)|eXoZymes (EXOZ) - Utang jangka dawa marang ekuitas|Oramed - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas Entera Bio Corp (ENTX)|HYFT: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas ABVC|cumberlandpharma.com (CPIX) - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal QNTM|Rasio utang jangka dawa marang ekuitas FibroGen Inc|Utang jangka dawa marang modal TELO|Utang jangka dawa marang modal RANI (ranitherapeutics.com)|Synergy CHC (SNYR) - Utang jangka dawa marang ekuitas|Rallybio Corp - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas LEXX (Lexaria)|Pulmatrix Inc (PULM) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas ftzy.com.cn PTHL|Aptorum Group (APM) - Koefisien utang jangka dawa marang modal|Lyra Therapeutics, Inc. - Utang jangka dawa marang modal|Tanggungan utang jangka dawa marang ekuitas IBO|TNF Pharmaceuticals (TNFA) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal YCBD (cbdmd.com)|PRFX: Utang jangka dawa marang ekuitas|CYTO - Kewajiban jangka dawa marang modal|Lipella Pharmaceuticals - Rasio utang jangka dawa marang ekuitas|OPTN: Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Pieris Pharmaceuticals, Inc. (PIRS)|Kewajiban jangka dawa marang ekuitas Petros Pharmaceuticals Inc|QLI - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal SLRN|TFFP (TFF Pharmaceuticals) - Utang jangka dawa marang ekuitas